TerminatedNot Applicable

Comparison of Standard of Care Guidelines for Mycoplasma Genitalium Infections Among Men With Non-gonococcal Urethritis

Stopped: Covid

United States10 participantsStarted 2019-11-19

Plain-language summary

The purpose of this protocol is to determine the difference in clearance of Mycoplasma genitalium (MG) when using the Australian management protocol versus the current Centers of Disease Control (CDC) treatment guidelines for US standard of care (SOC), to determine the proportion of men from the Deep South, with NGU attributable to MG, and to determine the proportion of MG cases that harbor the macrolide-resistance associated with mutation.

Who can participate

Age range18 Years – 99 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Presenting with symptoms of urethritis (dysuria and/or urethral discharge) Exclusion Criteria: * Non-English speaking

What they're measuring

Participants with Molecular Clearance

Timeframe: 90 days

Trial details

NCT IDNCT03910907

SponsorUniversity of Alabama at Birmingham

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-03-20

View on ClinicalTrials.gov More Mycoplasma Genitalium Infection trials